The dosage market size for Penicillins and Streptomycins in Croatia showed fluctuations from 2013 to 2023, reaching USD 22.712 million in 2023. Year-on-year variations reflect notable changes, such as a substantial increase of 14.51% in 2020, followed by moderate growth from 2021 to 2023. The five-year CAGR leading to 2023 shows a steady, albeit slow, growth, averaging at 0.84% annually. The market has depicted resilience, recovering from a low in 2019.
Future trends to watch for include technological advancements in drug delivery systems and the potential impact of healthcare policy shifts in Europe. Focus on sustainability and biotechnological innovations could also drive changes in this pharmaceutical sector.
How does Croatia rank in Penicillins and Streptomycins in Dosage Market Size Value?
| # | 33 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 4,303,400,000 | 2023 | +0.61% | +1.48% | View data |
| 2 | 2 United Kingdom | 730,000,000 | 2023 | -1.31% | -1.45% | View data |
| 3 | 3 France | 717,200,000 | 2023 | -1.91% | +0.034% | View data |
| 4 | 4 Italy | 622,330,000 | 2023 | -3.96% | -4.86% | View data |
| 5 | 5 Germany | 476,270,000 | 2023 | +1.03% | +1.1% | View data |
| 23 | 23 Bolivia | 29,241,000 | 2023 | +3.73% | +6.7% | View data |
| 24 | 24 El Salvador | 26,131,000 | 2023 | +1.87% | +2.32% | View data |
| 25 | 25 Croatia | 22,712,000 | 2023 | +1.18% | +0.84% | |
| 26 | 26 Morocco | 20,047,000 | 2023 | -0.6% | -1.22% | View data |
| 27 | 27 Ghana | 19,904,000 | 2023 | +0.28% | -1.55% | View data |
